Impact of comorbidity and venous thromboembolism on outcome in real-life non-small cell lung cancer (NSCLC) patients treated with immune checkpoint inhibition (ICI)

B. Bjoernhart, C. Kristiansen, K. H. Hansen, K. Wedervang, C. H. Nyhus, T. L. Jorgensen, J. Herrstedt, T. Schytte

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

OriginalsprogEngelsk
Artikelnummer54P
TidsskriftAnnals of Oncology
Vol/bind31
Udgave nummerSuppl. 7
Sider (fra-til)S1437
Antal sider1
ISSN0923-7534
DOI
StatusUdgivet - 1. dec. 2020
BegivenhedESMO Immuno-Oncology Virtual Congress -
Varighed: 9. dec. 202012. dec. 2020

Konference

KonferenceESMO Immuno-Oncology Virtual Congress
Periode09/12/202012/12/2020

Citationsformater